Qingnan Li

Biographic Data

ID7263194
NAMEQingnan Li
GIVEN NAMESQingnan
FAMILY NAMELi
SIGNATURELI Q
AFFILIATIONSZhejiang Chinese Medical University
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2024
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Knowledge, attitudes and practice toward refractive errors management among left-behind children of migrant workers

    Open AccessShuang Liu, Guang Yang et al.ARTICLEFrontiers in Public Health2025

    Background This study aimed to access knowledge, attitudes and practice (KAP) regarding refractive errors (RE) management among the left-behind children of migrant workers. Methods This cross-sectional study was performed by the Ophthalmology Department of Beijing Jishuitan Hospital between July and August, 2023. The KAP scores were assessed using a self-designed questionnaire. Results Analysis of 350 questionnaires showed mean KAP scores of 9.21…

  • Shuang Bailian mixture enhanced the anti-cancer effect of cisplatin by regulating PI3K-Akt-Bcl 2 signaling pathway

    Open AccessYilin Zheng, Xiaoyan Li et al.ARTICLEJournal of Ethnopharmacology2025

    Our study revealed the underlying mechanisms that SBLM enhanced the anti-cancer effect of CP through inhibiting the PI3K/Akt/Bcl-2 signaling pathway to induce the cells apoptosis. These results suggest that SBLM could serve as a promising adjuvant in chemotherapeutic regimens for EC

  • Long-term distress throughout one’s life

    Open AccessWanxian Liang, Shihuan Cao et al.ARTICLEFrontiers in Public Health2024

    Introduction Neurofibromatosis type 1 (NF1) is a rare genetic disorder, with lack of evidence of disease burden in China. We aimed to describe the economic burden, health-related quality of life (HRQL), and caregiver burden of NF1 patients in China. Methods We conducted an online cross-sectional survey employing the China Cloud Platform for Rare Diseases, with 223 caregivers of NF1 pediatric patients (patients under 18), and 226 adult patients. E…